logo
logo

NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

01/23/24, 1:02 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgaventura
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgtampa
Industry
genetics
therapeutics
biotechnology
health care
NAYA Biosciences Inc. has entered into a binding letter of intent to acquire Florida Biotechnologies, Inc., a gene therapy company focusing on the treatment of mitochondrial diseases. The acquisition is aimed at accelerating clinical development and early patient access to a breakthrough AAV gene therapy platform for mitochondrial genetic diseases, particularly targeting LHON.

Company Info

Company
NAYA Biosciences
Location
Aventura, Florida, United States
Company info
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. Our unique capabilities in biology, cell and gene therapy, and artificial intelligence provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough treatments.